BRL-42715
BRL-42715 is a potent inhibitor of a broad range of bacterial beta-lactamases (β-lactamase) [1].
Product Specifications
CAS Number
[102209-75-6]
UNSPSC
12352005
Target
Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/brl-42715.html
Solubility
10 mM in DMSO
Smiles
O=C(C(N1C/2=O)=CS[C@]1([H])C2=C/C3=CN(C)N=N3)O[Na]
Molecular Formula
C10H7N4NaO3S
Molecular Weight
286.24
References & Citations
[1]Coleman K, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.|[2]K Coleman, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6302758-01 0.2 mL
GLYCTK, NT (GLYCTK, HBEBP4, Glycerate kinase, HBeAg-binding protein 4) (Azide free) (HRP)
Ask
View Details MBS6302758-02 5x 0.2 mL
GLYCTK, NT (GLYCTK, HBEBP4, Glycerate kinase, HBeAg-binding protein 4) (Azide free) (HRP)
Ask
View Details 
GTR15357987 1 Vial
Lentiviral human FGFRL1 sgRNA gene knockout kit - Lentiviral human FGFRL1 sgRNA gene knockout kit (25)
Ask
View Details